A Case-Based Look at Exacerbation Prevention
Clinical Resource Center
Meeting Slides
Guidelines
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2019 report.
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
Wedzicha JA, et al. Eur Respir J. 2017;50(3):1602265.
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
Papi A, et al. Eur Respir J. 2017;49(3):1600791.
Clinical Practice Tools
The COPD Foundation Pocket Consultant Guide Mobile App
The COPD Pocket Guide, provided by the COPD Foundation, contains comprehensive management information as well as resource tools. It can be downloaded on any mobile device.
Modified Medical Research Council (mMRC) Dyspnea Scale
Modified Medical Research Council (mMRC) Dyspnea Scale
COPD Assessment Test (CAT)
The CAT, provided by the American Academy of Family Physicians, allows assessment of the global impact of COPD (cough, sputum, dyspnea, chest tightness) on patient health status.
COPD Action Plan
The COPD Action Plan, provided by the American Lung Association, is a tool that facilitates the prevention, timely identification, and early and appropriate treatment of COPD exacerbations.
Suggested Readings
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.
Yawn BP, et al. Int J Chron Obstruct Pulmon Dis. 2012;7:495-502.
Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.
Yawn BP, Thomashow B. Int J Gen Med. 2011;4:665-676.
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.
Puhan MA, et al. Cochrane Database Syst Rev. 2016;12:CD005305.
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.
Spruit MA, et al. Am J Respir Crit Care Med. 2013;188(8):e13-e64.
Reducing chronic obstructive pulmonary disease hospital readmissions. An official American Thoracic Society workshop report.
Press VG, et al. Ann Am Thorac Soc. 2019;16(2):161-170.
Triple versus dual inhaler therapy in moderate‐to‐severe COPD: a systematic review and meta‐analysis of randomized controlled trials.
Zayed Y, et al. Clin Respir J. 2019;13(7):413-428.
Once-daily single-inhaler triple versus dual therapy in patients with COPD.
Lipson DA, et al. N Engl J Med. 2018; 378(18):1671-1680.
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicenter, phase 3 randomized controlled trial.
Ferguson GT, et al. Lancet Respir Med. 2018; 6(10):747-758.
Patient Advocacy Organizations and Resources
American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.
COPD Foundation
The COPD Foundation’s mission is to prevent and cure COPD and to improve the lives of all people affected by COPD.
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
GOLD partners with health care professionals and public health officials to raise awareness of COPD and to improve prevention and treatment of this lung disease for patients around the world.
National Jewish Health
National Jewish Health integrates the latest scientific discoveries with coordinated care for lung, heart, and immune diseases. Their Patient Education Program provides many free educational opportunities and support groups to assist patients and caregivers with managing illnesses and chronic conditions, such as COPD.
A Case-Based Look at Exacerbation Prevention
A Case-Based Look at Exacerbation Prevention
Relevant Resources
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
A New Era in Precision Medicine
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Evolving Best Practices to Optimize Outcomes
Consensus and Controversies on the Road to Precision Medicine
Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care
The PCP’s Role in Timely Recognition and Referral
Debates and Discussions About Personalizing Patient Management
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
From Guideline Recommendations to Daily Clinical Decision-Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Improving Patient Outcomes Through Shared Clinical Decision Making
Digging Deep on Shared Decision-Making
Mechanistic Insights and Evolving Treatment Options
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
Mechanistic Insights and Emerging Treatment Options
A PrEP Primer
A Foundation for Managed Care
A Focus on Exacerbation Prevention
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
What the Pharmacist Needs to Know about PrEP
Evolving Best Practices for Patient Management
